Evogene (Israel) Investor Sentiment

EVGN Stock  ILA 503.60  3.80  0.76%   
About 51% of Evogene's investor base is interested to short. The analysis of current outlook of investing in Evogene suggests that many traders are impartial regarding Evogene's prospects. The current market sentiment, together with Evogene's historical and current headlines, can help investors time the market. In addition, many technical investors use Evogene stock news signals to limit their universe of possible portfolio assets.
  
few days ago at news.google.com         
Evogene Ltd. Earnings Call Growth Amid Challenges - TipRanks
Google News at Macroaxis
six days ago at news.google.com         
StockNews.com Begins Coverage on Evogene - Defense World
Google News at Macroaxis
over a week ago at news.google.com         
Evogene Q4 Earnings Snapshot - Barchart
Google News at Macroaxis
over a week ago at news.google.com         
Evogene earnings beat by 0.66, revenue fell short of estimates - Investing.com
Google News at Macroaxis
over two weeks ago at news.google.com         
Evogene Now Covered by StockNews.com - Defense World
Google News at Macroaxis
over three weeks ago at news.google.com         
Evogene Schedules Fourth Quarter 2024 Financial Results Release - Yahoo Finance
Google News at Macroaxis
over a month ago at news.google.com         
AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease - Marketsc...
Google News at Macroaxis
over a month ago at news.google.com         
Evogene Shareholders Approve Key Proposal in Special Meeting - TipRanks
Google News at Macroaxis
over a month ago at news.google.com         
Evogene Ltd. Reschedules Special General Meeting Due to Lack of Quorum - TipRanks
Google News at Macroaxis
over a month ago at news.google.com         
Evogene Ltd. Announces Conclusion of Employment of Eyal Ronen as Executive Vice President of Busines...
Google News at Macroaxis
over a month ago at news.google.com         
Evogene Announces Management Restructuring - TipRanks
Google News at Macroaxis
over two months ago at news.google.com         
Evogene Announces Special General Meeting to Approve Share Options for CEO - TipRanks
Google News at Macroaxis
over two months ago at news.google.com         
Evogene stock touches 52-week low at 1.25 amid market challenges - Investing.com Australia
Google News at Macroaxis
over three months ago at news.google.com         
Evogene stock touches 52-week low at 1.44 amid market challenges - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
Evogene Ltd Q3 2024 Earnings Call Highlights Navigating Challenges and Seizing Opportunities - Yahoo...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Evogene that are available to investors today. That information is available publicly through Evogene media outlets and privately through word of mouth or via Evogene internal channels. However, regardless of the origin, that massive amount of Evogene data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Evogene news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Evogene relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Evogene's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Evogene alpha.

Evogene Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Evogene Stock analysis

When running Evogene's price analysis, check to measure Evogene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evogene is operating at the current time. Most of Evogene's value examination focuses on studying past and present price action to predict the probability of Evogene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evogene's price. Additionally, you may evaluate how the addition of Evogene to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments